{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:55:14Z","timestamp":1790610914966,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,13]]},"DOI":"10.7759\/cureus.112605","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:48:13Z","timestamp":1783968493000},"source":"Crossref","is-referenced-by-count":1,"title":["Procalcitonin and C-reactive Protein in Septicaemia: Correlation With Bacterial Profile and Antimicrobial Resistance in ICU Setting"],"prefix":"10.7759","author":[{"given":"Vishakha S","family":"Pawar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra V","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11111581","article-title":"Evolution of the concept of sepsis","volume":"11","author":"Jean-Louis Vincent","year":"2022","unstructured":"Jean-Louis Vincent . Evolution of the concept of sepsis. Antibiotics (Basel). 2022, 11:1581. 10.3390\/antibiotics11111581","journal-title":"Antibiotics (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/1871529x15666150108114810","article-title":"Sepsis pathophysiology and anesthetic consideration","volume":"15","author":"Yuki K","year":"2015","unstructured":"Yuki K, Murakami N. Sepsis pathophysiology and anesthetic consideration. Cardiovasc Hematol Disord Drug Targets. 2015, 15:57-69. 10.2174\/1871529x15666150108114810","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus DC","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013, 369:840-51. 10.1056\/NEJMra1208623","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016, 315:723-832. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy MM","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, et al.. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Crit Care Med. 2003, 31:1250-6. 10.1097\/01.CCM.0000050454.01978.3B","journal-title":"Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1150103","article-title":"C-reactive protein - my perspective on its first half century, 1930-1982","volume":"14","author":"Kushner I","year":"2023","unstructured":"Kushner I. C-reactive protein - my perspective on its first half century, 1930-1982. Front Immunol. 2023, 14:1150103. 10.3389\/fimmu.2023.1150103","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/cc8872","article-title":"Sepsis biomarkers: a review","volume":"14","author":"Pierrakos C","year":"2010","unstructured":"Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010, 14:R15. 10.1186\/cc8872","journal-title":"Crit Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/cc11202","article-title":"Bench-to-bedside review: rapid molecular diagnostics for bloodstream infection--a new frontier?","volume":"16","author":"Afshari A","year":"2012","unstructured":"Afshari A, Schrenzel J, Ieven M, Harbarth S. Bench-to-bedside review: rapid molecular diagnostics for bloodstream infection--a new frontier?. Crit Care. 2012, 16:222. 10.1186\/cc11202","journal-title":"Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00487-x","article-title":"Rapid diagnosis of bloodstream infections using a culture-free phenotypic platform","volume":"4","author":"Shi X","year":"2024","unstructured":"Shi X, Sharma S, Chmielewski RA, Markovic MJ, VanEpps JS, Yau ST. Rapid diagnosis of bloodstream infections using a culture-free phenotypic platform. Commun Med (Lond). 2024, 4:77. 10.1038\/s43856-024-00487-x","journal-title":"Commun Med (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8030346","article-title":"Classical microbiological diagnostics of bacteremia: are the negative results really negative? What is the laboratory result telling us about the \"gold standard\"?","volume":"8","author":"\u0179r\u00f3d\u0142owski T","year":"2020","unstructured":"\u0179r\u00f3d\u0142owski T, Sobo\u0144ska J, Salamon D, McFarlane IM, Zi\u0119tkiewicz M, Gosiewski T. Classical microbiological diagnostics of bacteremia: are the negative results really negative? What is the laboratory result telling us about the \"gold standard\"?. Microorganisms. 2020, 8:346. 10.3390\/microorganisms8030346","journal-title":"Microorganisms"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-7-137","article-title":"Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults","volume":"7","author":"Massaro KS","year":"2007","unstructured":"Massaro KS, Costa SF, Leone C, Chamone DA. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis. 2007, 7:137. 10.1186\/1471-2334-7-137","journal-title":"BMC Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-2-32","article-title":"Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review","volume":"2","author":"P\u00f3voa P","year":"2012","unstructured":"P\u00f3voa P, Salluh JI. Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review. Ann Intensive Care. 2012, 2:32. 10.1186\/2110-5820-2-32","journal-title":"Ann Intensive Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys MB","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003, 111:1805-12. 10.1172\/JCI18921","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14071413","article-title":"Relationship of ferritin and procalcitonin with SOFA-2 scores in intensive care patients with COVID-19-associated sepsis: a cross-sectional analysis","volume":"14","author":"Ay M","year":"2026","unstructured":"Ay M, Orhan S, Demirt\u00fcrk N, Bozkurt E, Sari A, Ay M. Relationship of ferritin and procalcitonin with SOFA-2 scores in intensive care patients with COVID-19-associated sepsis: a cross-sectional analysis. Biomed. 2026, 14:1413. 10.3390\/biomedicines14071413","journal-title":"Biomed"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4873074","article-title":"Diagnostic accuracy of procalcitonin compared to C-reactive protein and interleukin 6 in recognizing gram-negative bloodstream infection: a meta-analytic study","volume":"2020","author":"Lai L","year":"2020","unstructured":"Lai L, Lai Y, Wang H, et al.. Diagnostic accuracy of procalcitonin compared to C-reactive protein and interleukin 6 in recognizing gram-negative bloodstream infection: a meta-analytic study. Dis Markers. 2020, 2020:4873074. 10.1155\/2020\/4873074","journal-title":"Dis Markers"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00016-12","article-title":"New approaches to sepsis: molecular diagnostics and biomarkers","volume":"25","author":"Reinhart K","year":"2012","unstructured":"Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012, 25:609-34. 10.1128\/CMR.00016-12","journal-title":"Clin Microbiol Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd KE","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al.. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020, 395:200-11. 10.1016\/S0140-6736(19)32989-7","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin GS","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348:1546-54. 10.1056\/NEJMoa022139","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/2049-9957-3-21","article-title":"Global burden, distribution, and interventions for infectious diseases of poverty","volume":"3","author":"Bhutta ZA","year":"2014","unstructured":"Bhutta ZA, Sommerfeld J, Lassi ZS, Salam RA, Das JK. Global burden, distribution, and interventions for infectious diseases of poverty. Infect Dis Poverty. 2014, 3:21. 10.1186\/2049-9957-3-21","journal-title":"Infect Dis Poverty"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit","volume":"5","author":"Sakr Y","year":"2018","unstructured":"Sakr Y, Jaschinski U, Wittebole X, et al.. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis. 2018, 5:ofy313. 10.1093\/ofid\/ofy313","journal-title":"Open Forum Infect Dis"},{"key":"ref21","article-title":"Laboratory evaluation of sepsis: integrating biomarkers, organ dysfunction scores, and management","author":"Karunarathna I","year":"2025","unstructured":"Karunarathna I, Aluthge P, Senanayake K, et al.. Laboratory evaluation of sepsis: integrating biomarkers, organ dysfunction scores, and management. Uva Clin Anaesth Intensive Care. 2025,","journal-title":"Uva Clin Anaesth Intensive Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021, 47:1181-247. 10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.04.04","article-title":"Biomarker-guided antibiotic therapy-strengths and limitations","volume":"5","author":"Nora D","year":"2017","unstructured":"Nora D, Salluh J, Martin-Loeches I, P\u00f3voa P. Biomarker-guided antibiotic therapy-strengths and limitations. Ann Transl Med. 2017, 5:208. 10.21037\/atm.2017.04.04","journal-title":"Ann Transl Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61815-7","article-title":"Sepsis definitions: time for change","volume":"381","author":"Vincent JL","year":"2013","unstructured":"Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 2013, 381:774-5. 10.1016\/S0140-6736(12)61815-7","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1586\/eri.12.50","article-title":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes","volume":"10","author":"Martin GS","year":"2012","unstructured":"Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012, 10:701-6. 10.1586\/eri.12.50","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14070700","article-title":"Evaluation of infections caused by carbapenem-resistant Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae in an intensive care unit: a retrospective study","volume":"14","author":"Kerimoglu E","year":"2025","unstructured":"Kerimoglu E, Catak T, Kilinc A. Evaluation of infections caused by carbapenem-resistant Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae in an intensive care unit: a retrospective study. Antibiotics (Basel). 2025, 14:700. 10.3390\/antibiotics14070700","journal-title":"Antibiotics (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/9781555819040.ch25","article-title":"Bloodstream infections","author":"Martinez RM","year":"2016","unstructured":"Martinez RM, Wolk DM. Bloodstream infections. Diagnostic Microbiology of the Immunocompromised Host. Hayden RT, Wolk DM, Carroll KC, Tang YW (ed): ASM Press, Washington, DC; 2016. 10.1128\/9781555819040.ch25"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01835-13","article-title":"Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles","volume":"51","author":"Altun O","year":"2013","unstructured":"Altun O, Almuhayawi M, Ullberg M, Ozenci V. Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol. 2013, 51:4130-6. 10.1128\/JCM.01835-13","journal-title":"J Clin Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00053-14","article-title":"Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis","volume":"29","author":"Buehler SS","year":"2016","unstructured":"Buehler SS, Madison B, Snyder SR, et al.. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev. 2016, 29:59-103. 10.1128\/CMR.00053-14","journal-title":"Clin Microbiol Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar A","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, et al.. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006, 34:1589-96. 10.1097\/01.CCM.0000217961.75225.E9","journal-title":"Crit Care Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes A","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, et al.. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017, 43:304-77. 10.1007\/s00134-017-4683-6","journal-title":"Intensive Care Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021444","article-title":"Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors","volume":"89","author":"Becker KL","year":"2004","unstructured":"Becker KL, Nyl\u00e9n ES, White JC, M\u00fcller B, Snider RH Jr. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004, 89:1512-25. 10.1210\/jc.2002-021444","journal-title":"J Clin Endocrinol Metab"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2014.08.002","article-title":"Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment","volume":"22","author":"Shaikh S","year":"2015","unstructured":"Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment. Saudi J Biol Sci. 2015, 22:90-101. 10.1016\/j.sjbs.2014.08.002","journal-title":"Saudi J Biol Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/s17030480","article-title":"Rapid and sensitive lateral flow immunoassay method for procalcitonin (PCT) based on time-resolved immunochromatography","volume":"17","author":"Shao XY","year":"2017","unstructured":"Shao XY, Wang CR, Xie CM, Wang XG, Liang RL, Xu WW. Rapid and sensitive lateral flow immunoassay method for procalcitonin (PCT) based on time-resolved immunochromatography. Sensors (Basel). 2017, 17:480. 10.3390\/s17030480","journal-title":"Sensors (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493566-procalcitonin-and-c-reactive-protein-in-septicaemia-correlation-with-bacterial-profile-and-antimicrobial-resistance-in-icu-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:48:15Z","timestamp":1783968495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493566-procalcitonin-and-c-reactive-protein-in-septicaemia-correlation-with-bacterial-profile-and-antimicrobial-resistance-in-icu-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.112605","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}